Literature DB >> 27634128

Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.

Yashashwi Pokharel, Kensey Gosch, Vijay Nambi, Paul S Chan, Mikhail Kosiborod, William J Oetgen, John A Spertus, Christie M Ballantyne, Laura A Petersen, Salim S Virani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27634128      PMCID： PMC5250510          DOI： 10.1016/j.jacc.2016.06.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  1 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson; Karen M Eddleman; Nicole M Jarrett; Ken LaBresh; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690
  1 in total
  13 in total

1.  Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database.

Authors:  Hasan Rehman; Julia M Akeroyd; David Ramsey; Sarah T Ahmed; Anwar T Merchant; Sankar D Navaneethan; Laura A Petersen; Salim S Virani
Journal:  Clin Cardiol       Date:  2017-08-25       Impact factor: 2.882

2.  Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD.

Authors:  Sankar D Navaneethan; Julia M Akeroyd; David Ramsey; Sarah T Ahmed; Shiva Raj Mishra; Laura A Petersen; Paul Muntner; Christie Ballantyne; Wolfgang C Winkelmayer; Venkat Ramanathan; Salim S Virani
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-29       Impact factor: 8.237

Review 3.  Cardiovascular Disease Prevention: Training Opportunities, the Challenges, and Future Directions.

Authors:  Anum Saeed; Kaustubh Dabhadkar; Salim S Virani; Peter H Jones; Christie M Ballantyne; Vijay Nambi
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.113

4.  Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs.

Authors:  Dhruv Mahtta; David J Ramsey; Michelle T Lee; Liang Chen; Mahmoud Al Rifai; Julia M Akeroyd; Elizabeth M Vaughan; Michael E Matheny; Karla Rodrigues do Espirito Santo; Sankar D Navaneethan; Carl J Lavie; Yochai Birnbaum; Christie M Ballantyne; Laura A Petersen; Salim S Virani
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

5.  Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry.

Authors:  Angela Lowenstern; Shuang Li; Salim S Virani; Ann Marie Navar; Zhuokai Li; Jennifer G Robinson; Veronique L Roger; Anne C Goldberg; Andrew Koren; Michael J Louie; Eric D Peterson; Tracy Y Wang
Journal:  Am Heart J       Date:  2020-04-30       Impact factor: 4.749

6.  Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.

Authors:  Zak Loring; Peter Shrader; Larry A Allen; Rosalia Blanco; Paul S Chan; Michael D Ezekowitz; Gregg C Fonarow; James V Freeman; Bernard J Gersh; Kenneth W Mahaffey; Gerald V Naccarelli; Karen Pieper; James A Reiffel; Daniel E Singer; Benjamin A Steinberg; Laine E Thomas; Eric D Peterson; Jonathan P Piccini
Journal:  Am Heart J       Date:  2019-11-08       Impact factor: 4.749

7.  Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.

Authors:  Salim S Virani; Kevin F Kennedy; Julia M Akeroyd; Pamela B Morris; Vera A Bittner; Frederick A Masoudi; Neil J Stone; Laura A Petersen; Christie M Ballantyne
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-05

8.  Prevalence of statin use among high-risk patients in urban and rural Vellore, Tamil Nadu: A population-based cross-sectional study.

Authors:  Anu Mary Oommen; Khushboo Nand; Vinod Joseph Abraham; Kuryan George; V Jacob Jose
Journal:  Indian J Pharmacol       Date:  2017 Mar-Apr       Impact factor: 1.200

9.  Patient-Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry.

Authors:  Corey K Bradley; Tracy Y Wang; Shuang Li; Jennifer G Robinson; Veronique L Roger; Anne C Goldberg; Salim S Virani; Michael J Louie; L Veronica Lee; Eric D Peterson; Ann Marie Navar
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

10.  Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin-controlled LDL cholesterol.

Authors:  Gregory A Nichols; Sephy Philip; Kristi Reynolds; Craig B Granowitz; Sergio Fazio
Journal:  Diabetes Obes Metab       Date:  2018-10-14       Impact factor: 6.577
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.